MRD in Venetoclax-Based Treatment for AML: Does it Really Matter?

Overview of attention for article published in Frontiers in oncology, July 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 21 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 7,467 followers.

New article: MRD in Venetoclax-Based Treatment for AML: Does it Really Matter? https://t.co/Tl3BkfMhuV #AML #leusm #hematology https://t.co/boa3FefmYp

04 Aug 2022

Reply Repost Favourite

New research: MRD in Venetoclax-Based Treatment for AML: Does it Really Matter?: The prognosis of newly diagnosed patients with acute myeloid leukemia is still unfavorable in the majority of cases within the intermediate and mainly adverse… https://t.co/3N

19 Jul 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.